CardieX Limited (ASX:CDX)
Australia
· Delayed Price · Currency is AUD 0.0610
0.00 (0.00%)
Apr 24, 2025, 12:34 PM AEST
CardieX Revenue
CardieX had revenue of 3.29M AUD in the half year ending December 31, 2024, with 72.13% growth. This brings the company's revenue in the last twelve months to 5.72M, down -59.58% year-over-year. In the fiscal year ending June 30, 2024, CardieX had annual revenue of 12.81M with 125.14% growth.
Revenue (ttm)
5.72M
Revenue Growth
-59.58%
P/S Ratio
4.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 12.81M | 7.12M | 125.14% |
| Jun 30, 2023 | 5.69M | 953.17K | 20.12% |
| Jun 30, 2022 | 4.74M | 602.03K | 14.56% |
| Jun 30, 2021 | 4.14M | -642.40K | -13.44% |
| Jun 30, 2020 | 4.78M | 39.35K | 0.83% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |